GlassScriptPhysician profile
Audrey Romero
NPI 1942235692
$5,864.96
in general payments reported to CMS, 2019-2025
41 companies · $979 in 2025
The $979 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $899 · 2020: $1,610 · 2021: $381 · 2022: $951 · 2023: $629 · 2024: $417 · 2025: $979.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,945 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,944.70 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $2,123.66 | 2019-2020 | |
| Astellas Pharma US INC | $722.27 | 2021-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $476.15 | 2023-2025 | Myfembree, Gemtesa |
| Abbvie INC. | $399.77 | 2019-2023 | Liletta, Lo Loestrin Fe, Orilissa |
| Mayne Pharma Commercial LLC | $295.76 | 2021-2025 | |
| Agile Therapeutics, INC. | $183.38 | 2021-2024 | Twirla |
| Pfizer INC. | $144.78 | 2021-2024 | |
| Evofem Biosciences, INC. | $144.63 | 2021-2025 | Phexxi, Solosec, Phexx |
| Millicent US INC | $121.28 | 2019-2025 | Intrarosa, Femring, Femlyv |
| Exeltis, USA INC. | $121.13 | 2020-2025 | Slynd |
| Coopersurgical, INC. | $84.76 | 2019-2022 | |
| Therapeuticsmd, INC. | $82.84 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $74.88 | 2020-2024 | Gardasil 9, Gardasil |
| Bayer Healthcare Pharmaceuticals INC. | $70.37 | 2021-2022 | |
| Avion Pharmaceuticals | $65.75 | 2019-2022 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audrey Romero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.